•  
  •  
  •  
  •  

2025-11-04 19:46:23

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Suzlon Energy Ltd consolidated Q2FY26 PAT climbs to Rs. 1279.44 crores
  • Route Mobile Ltd consolidated Q2FY26 loss at Rs. 21.21 crores
  • Fabtech Technologies Limited Secures Rs. 52 Crore Contract
  • Power Grid Corporation of India Ltd declares interim dividend of Rs. 4.50
  • Kulin Lalbhai elevated as Chairman of Arvind SmartSpaces Limited

Keywords Selected:  INE947Q01028

Research

  • Q4FY22 Result Update – Laurus Labs - ICICI Direct

Stock Report

  • Laurus Labs Limited approves interim dividend of Rs. 0.80
  • Laurus Labs Ltd allotted 531.77 acres of land by the Government of Andhra Pradesh
  • Laurus Labs Limited approves 2nd interim dividend of Rs. 0.80
  • Laurus Labs Limited receives EIR for API facility Unit-4
  • Laurus Labs Limited invests in Laurus Bio Pvt Ltd
  • Laurus Labs Inaugurates New State of the Art R&D Facility at IKP Knowledge Park
  • Laurus Labs concludes successful USFDA audit for API Manufacturing Facility at Hyderabad
  • Laurus Labs Limited receives EIR from USFDA for API facilities
  • Laurus Labs Limited recommends 2nd interim dividend of Rs. 0.40
  • Laurus Labs Limited forms JV company
  • Laurus Labs enters into Joint Venture Agreement with KRKA, Slovenia
  • Laurus Synthesis Pvt Ltd receives Form 483 with 5 observations from USFDA
  • ImmunoACT announces the approval of India's first CAR-T cell therapy, NexCAR19
  • Laurus Labs Limited acquires stake in Laurus Bio Private Limited
  • Laurus Labs signs MOA with IIT Kanpur for novel gene therapy assets
  • Laurus Labs to increase stake in ImmunoACT to 33.86%
  • Laurus Labs receives USFDA tentative approval for the World's First Paediatric ARV Oral Dispersible Film drug, Dolutegravir 5mg and 10mg in HIV/AIDS treatment
  • Laurus Labs Ltd approves 2nd interim dividend of Rs. 1.20
  • Laurus Labs Limited updates on inspection at Formulations Facility
  • Laurus Labs Ltd receives EIR from USFDA for Unit 5, Parawada, Vizag
  • Laurus Labs Ltd gets one observation from USFDA for Pre-Approval Inspection
  • Laurus Labs Ltd approves interim dividend of Rs. 0.80
  • Laurus Labs Ltd Board approves 2nd interim dividend of Rs. 1.20
  • Laurus Labs receives orders from leading Global Life Sciences Company

Latest Post

  • Suzlon Energy Ltd consolidated Q2FY26 PAT climbs to Rs. 1279.44 crores
  • Route Mobile Ltd consolidated Q2FY26 loss at Rs. 21.21 crores
  • Fabtech Technologies Limited Secures Rs. 52 Crore Contract
  • Power Grid Corporation of India Ltd declares interim dividend of Rs. 4.50
  • Kulin Lalbhai elevated as Chairman of Arvind SmartSpaces Limited


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024